Product NDC: | 10191-1225 |
Proprietary Name: | APOMORPHINUM MURIATICUM |
Non Proprietary Name: | APOMORPHINE HYDROCHLORIDE |
Active Ingredient(s): | 3 [hp_X]/1 & nbsp; APOMORPHINE HYDROCHLORIDE |
Administration Route(s): | SUBLINGUAL |
Dosage Form(s): | PELLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10191-1225 |
Labeler Name: | Remedy Makers |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED HOMEOPATHIC |
Start Marketing Date: | 20020318 |
Package NDC: | 10191-1225-2 |
Package Description: | 153 PELLET in 1 VIAL, GLASS (10191-1225-2) |
NDC Code | 10191-1225-2 |
Proprietary Name | APOMORPHINUM MURIATICUM |
Package Description | 153 PELLET in 1 VIAL, GLASS (10191-1225-2) |
Product NDC | 10191-1225 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | APOMORPHINE HYDROCHLORIDE |
Dosage Form Name | PELLET |
Route Name | SUBLINGUAL |
Start Marketing Date | 20020318 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Labeler Name | Remedy Makers |
Substance Name | APOMORPHINE HYDROCHLORIDE |
Strength Number | 3 |
Strength Unit | [hp_X]/1 |
Pharmaceutical Classes | Dopamine Agonists [MoA],Dopaminergic Agonist [EPC] |